Showing 1 - 20 results of 33 for search 'Matthew R. Sydes', query time: 0.06s
Refine Results
-
1
-
2
Monitoring in practice – How are UK academic clinical trials monitored? A survey by Sharon B. Love, Victoria Yorke-Edwards, Sarah Lensen, Matthew R. Sydes
Published 2020-01-01
Article -
3
-
4
Prospective reporting of statistical analysis plans for randomised controlled trials by Karla Hemming, Anna Kearney, Carrol Gamble, Tianjing Li, Peter Jüni, An-Wen Chan, Matthew R. Sydes
Published 2020-10-01
Article -
5
Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system by Carlos Diaz-Montana, William J. Cragg, Rahela Choudhury, Nicola Joffe, Matthew R. Sydes, Sally P. Stenning
Published 2019-04-01
Article -
6
Data sharing and the evolving role of statisticians by Nick Manamley, Steve Mallett, Matthew R. Sydes, Sally Hollis, Alison Scrimgeour, Hans Ulrich Burger, Hans-Joerg Urban
Published 2016-07-01
Article -
7
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data by Sharon B. Love, Anna Kilanowski, Victoria Yorke-Edwards, Oliver Old, Hugh Barr, Clive Stokes, Catherine Kendall, Matthew R. Sydes
Published 2021-09-01
Article -
8
Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines by Hussein Ibrahim, Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, An-Wen Chan, Matthew R. Sydes, Melanie J. Calvert, Alastair K. Denniston
Published 2021-01-01
Article -
9
Mind the gap? The platform trial as a working environment by Liz Morrell, Joshua Hordern, Louise Brown, Matthew R. Sydes, Claire L. Amos, Richard S. Kaplan, Mahesh K. B. Parmar, Timothy S. Maughan
Published 2019-05-01
Article -
10
-
11
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 1; peer review: 2 approved] by Nurulamin M. Noor, Sarah L. Pett, Hanif Esmail, Angela M. Crook, Claire L. Vale, Matthew R. Sydes, Mahesh K.B. Parmar
Published 2020-09-01
Article -
12
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 2; peer review: 2 approved] by Nurulamin M. Noor, Sarah L. Pett, Hanif Esmail, Angela M. Crook, Claire L. Vale, Matthew R. Sydes, Mahesh K.B. Parmar
Published 2020-11-01
Article -
13
A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials by Elizabeth J. Conroy, Barbara Arch, Nicola L. Harman, J. Athene Lane, Steff C. Lewis, John Norrie, Matthew R. Sydes, Carrol Gamble
Published 2017-12-01
Article -
14
‘We all want to succeed, but we’ve also got to be realistic about what is happening’: an ethnographic study of relationships in trial oversight and their impact by Anne Daykin, Lucy E. Selman, Helen Cramer, Sharon McCann, Gillian W. Shorter, Matthew R. Sydes, Carrol Gamble, Rhiannon Macefield, J. Athene Lane, Alison Shaw
Published 2017-12-01
Article -
15
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries by Sarah Lensen, Archie Macnair, Sharon B. Love, Victoria Yorke-Edwards, Nurulamin M. Noor, Meredith Martyn, Alexandra Blenkinsop, Carlos Diaz-Montana, Graham Powell, Elizabeth Williamson, James Carpenter, Matthew R. Sydes
Published 2020-05-01
Article -
16
Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons by Dominic Hague, Stephen Townsend, Lindsey Masters, Mary Rauchenberger, Nadine Van Looy, Carlos Diaz-Montana, Melissa Gannon, Nicholas James, Tim Maughan, Mahesh K. B. Parmar, Louise Brown, Matthew R. Sydes, for the STAMPEDE and FOCUS4 investigators
Published 2019-05-01
Article -
17
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial. by Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis, Elizabeth C James, Carlos Diaz-Montana, William J Cragg, Conor Tweed, Archie Macnair, Matthew R Sydes, Claire Snowdon, Katie Gillies, Talia Isaacs, Barbara E Bierer, Andrew J Copas
Published 2021-10-01
Article -
18
Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Re... by Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Published 2023-11-01
Article -
19
Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partn... by Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Published 2023-10-01
Article -
20
Adaptive designs in clinical trials: why use them, and how to run and report them by Philip Pallmann, Alun W. Bedding, Babak Choodari-Oskooei, Munyaradzi Dimairo, Laura Flight, Lisa V. Hampson, Jane Holmes, Adrian P. Mander, Lang’o Odondi, Matthew R. Sydes, Sofía S. Villar, James M. S. Wason, Christopher J. Weir, Graham M. Wheeler, Christina Yap, Thomas Jaki
Published 2018-02-01
Article